Florida A&M University (FAMU) has lost a significant grant that helped produced 60% of the nation’s Ph.D. graduates in pharmaceutical sciences.
According to the Tallahassee Democrat, the Historically Black College and University’s (HBCU) pharmacy school and its Research Centers in Minority Institutions (RCMI) program will not receive planned funding because a $16.3 million grant supporting them was terminated on March 21. The grant, awarded by the National Institutes of Health (NIH) and renewed in 2024, was originally scheduled to run through March 2029.
“The funding was awarded to support new faculty hires and enhanced research in key areas such as artificial intelligence, bioinformatics and cancer biology,” FAMU Interim President Timothy Beard said in a statement, according to the outlet. “For nearly 40 years, faculty and graduate students have relied on this center to conduct biomedical and health research.”
He also mentioned, “The program is a critical contributor to the university’s ability to produce 60% of the nation’s Ph.D. graduates in pharmaceutical sciences from various backgrounds. The RCMI program plays a vital role in ensuring the state’s success by contributing to the pipeline of highly trained professionals in the healthcare industry.”
The closure of the grant program coincides with changes caused under President Donald Trump’s leadership. As AFROTECH™ previously told you, he signed various executive orders that share a common goal of eliminating diversity, equity, and inclusion (DEI) initiatives, programs, and roles at the federal level. He has also threatened to cut federal spending for schools and universities that continued to uphold DEI commitments.
It is unclear how many other grants have been terminated at FAMU, but its vice president for research, Charles Weatherford, acknowledged that “concerning the activity around federal guidance on research funding, developments are occurring almost every day.”
“For example, a federal grant involving climate studies, wherein FAMU is a subcontractor, experienced a spending freeze. Note the grant was not terminated. Several such halts have occurred and then were restarted after a short halt,” he continued.
At the time of this writing, FAMU is “in the process of appealing the decision.” As part of its Day of Giving April 3-4, the school is encouraging donations to support the efforts of the pharmacy school and other institutions and projects.
The funding will be put toward “advancing research in public health initiatives, such as addressing health disparities, improving health outcomes in underserved communities and preparing students to tackle global health challenges,” notes Seth Ablordeppey, interim dean of FAMU’s College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health.